Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Acetylsalicylic acid and phenobarbitone are better absorbed from the stomach because they are:

Weak acids that remain non-ionic in gastric pH. ### Explanation **1. Why Option A is Correct: The pH Partition Hypothesis** Drug absorption across biological membranes occurs primarily via **passive diffusion**. For a drug to diffuse through the lipid bilayer of the stomach lining, it must be in its **lipid-soluble, non-ionized (uncharged) form**. According to the Henderson-Hasselbalch equation, **weak acids** (like Aspirin/Acetylsalicylic acid and Phenobarbitone) exist predominantly in their non-ionized form in an acidic environment (low pH). Since the gastric pH is highly acidic (~1–2), these drugs remain uncharged and are readily absorbed through the gastric mucosa. **2. Why the Other Options are Incorrect:** * **Option B:** If weak acids were ionic in the stomach, they would be water-soluble and lipid-insoluble, preventing them from crossing the lipid membrane. * **Option C:** Strong acids (like HCl) are almost completely ionized regardless of pH. High ionization prevents passive diffusion across membranes. * **Option D:** Weak bases (e.g., Atropine, Morphine) become **ionized** (protonated) in acidic environments. This "traps" them in the stomach, preventing absorption until they reach the more alkaline environment of the small intestine. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ion Trapping:** This principle is used to treat toxicity. To accelerate the excretion of a **weak acid** (like Phenobarbitone or Salicylates), we **alkalinize the urine** with Sodium Bicarbonate. This ionizes the drug in the renal tubules, preventing reabsorption and "trapping" it in the urine for excretion. * **Site of Absorption:** Although weak acids are chemically favored for absorption in the stomach, the **small intestine** remains the major site of absorption for *most* drugs (including weak acids) due to its massive surface area (villi/microvilli). * **Pka:** When pH = pKa, 50% of the drug is ionized and 50% is non-ionized.

Q: Which of the following is an example of a Phase I xenobiotic reaction?

Hydroxylation. Drug metabolism (biotransformation) occurs in two distinct phases to convert lipophilic drugs into hydrophilic metabolites for excretion [1, 2]. **Phase I Reactions (Nonsynthetic)** These reactions involve the introduction or unmasking of a functional group (like –OH, –NH2, or –SH). The primary goal is to make the molecule more polar or prepare it for Phase II [2]. * **Hydroxylation** is a classic example of an **Oxidation** reaction, which is the most common Phase I process, typically mediated by the Cytochrome P450 (CYP450) enzyme system [2]. Other Phase I reactions include reduction and hydrolysis [1, 2]. **Explanation of Incorrect Options** Options A, C, and D are all **Phase II Reactions (Synthetic)**. These involve the **conjugation** of a drug or its Phase I metabolite with an endogenous substance to form a highly polar, inactive conjugate [2]. * **Acetylation (A):** Catalyzed by NAT enzymes (e.g., Isoniazid, Hydralazine) [1]. * **Methylation (C):** Transfer of a methyl group (e.g., Epinephrine, Dopamine). * **Glucuronidation (D):** The most common Phase II reaction, catalyzed by UGT enzymes (e.g., Morphine, Bilirubin) [2]. **High-Yield NEET-PG Pearls:** * **Mnemonic for Phase II:** "S-M-A-G" (Sulfation, Methylation, Acetylation, Glucuronidation). * **Exception:** Most Phase II metabolites are inactive [1], but **Morphine-6-glucuronide** is more potent than morphine itself. * **Microsomal vs. Non-microsomal:** Glucuronidation is the only Phase II reaction that occurs in the microsomes; all others are non-microsomal (cytosolic). * **Age Factor:** Neonates are deficient in glucuronidation, leading to **Gray Baby Syndrome** with Chloramphenicol.

Q: Which drug follows first-order kinetics for elimination?

All of the above. **Explanation:** The correct answer is **D. All of the above.** **Underlying Concept: First-Order vs. Zero-Order Kinetics** Most drugs follow **First-Order Kinetics**, where a constant *fraction* of the drug is eliminated per unit of time. The rate of elimination is directly proportional to the plasma concentration. In contrast, **Zero-Order Kinetics** occurs when a constant *amount* of drug is eliminated per unit of time because the elimination pathways (enzymes/transporters) are saturated. **Analysis of Options:** * **Opioids (e.g., Morphine):** These are metabolized primarily by the liver via glucuronidation. At therapeutic doses, the enzymes are not saturated, following first-order kinetics. * **Verapamil:** A calcium channel blocker that undergoes extensive first-pass metabolism. It follows first-order kinetics, meaning its half-life remains constant regardless of the dose. * **Lignocaine:** An amide local anesthetic and antiarrhythmic. It is cleared by the liver with a high extraction ratio, following first-order kinetics under normal physiological conditions. **High-Yield Clinical Pearls for NEET-PG:** To excel in NEET-PG, it is more efficient to memorize the exceptions—drugs that follow **Zero-Order Kinetics** (Non-linear kinetics)—using the mnemonic **"WATT P"**: * **W**arfarin * **A**lcohol (Ethanol) * **T**heophylline * **T**olbutamide * **P**henytoin / **P**ropanol (at high doses) / **P**yrazinamide / **P**alicylates (Aspirin) **Key Distinction:** For first-order drugs, the **Half-life ($t_{1/2}$)** is constant. For zero-order drugs, the half-life varies with the dose, increasing as the plasma concentration increases.

Q: Steady-state plasma concentration obtained after a dosage regimen depends on which of the following?

Dosing rate. **Explanation:** The **Steady-State Concentration ($C_{ss}$)** is the point during a drug dosage regimen where the rate of drug administration (input) equals the rate of drug elimination (output) [1]. **1. Why "Dosing Rate" is Correct:** The fundamental formula for steady-state concentration is: $C_{ss} = \frac{\text{Dosing Rate}}{\text{Clearance (CL)}}$ [1] The **Dosing Rate** is the amount of drug administered per unit of time (e.g., mg/hr). Since $C_{ss}$ is directly proportional to the dosing rate, any change in the rate of administration will directly alter the plateau concentration [3]. If you double the dosing rate, you double the $C_{ss}$. **2. Why the Other Options are Incorrect:** * **Duration of Action (A):** This is a clinical effect of the drug's pharmacodynamics and half-life, not a determinant of the plasma level achieved at steady state. * **Half-life ($t_{1/2}$) (C):** This is a common distractor. Half-life determines the **time taken** to reach steady state (usually 4–5 half-lives), but it does not determine the **level (concentration)** of the steady state itself [3]. * **Dosage Interval (D):** While the interval affects the "fluctuations" (peaks and troughs) between doses, the average $C_{ss}$ is determined by the total dosing rate (Dose/Interval) [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Time to Steady State:** It takes approximately **4 to 5 half-lives** to reach steady state, regardless of the dose or dosing interval [3]. * **Loading Dose:** Used to achieve therapeutic levels rapidly (bypassing the 4–5 half-lives wait), but it does not change the final $C_{ss}$ [2]. * **Maintenance Dose:** Calculated based on Clearance to maintain the $C_{ss}$ [1]. * **Key Formula:** $\text{Dosing Rate} = C_{ss} \times \text{Clearance}$.

Q: What is the most important factor governing the absorption of a drug from intact skin?

Lipid solubility of the drug. The absorption of drugs through intact skin (transdermal absorption) occurs primarily via passive diffusion through the stratum corneum, the outermost layer of the epidermis [1]. This layer acts as a lipid-rich, semi-permeable barrier. 1. Why Lipid Solubility is Correct: The stratum corneum is composed of keratinized cells embedded in a lipid matrix. For a drug to penetrate this barrier, it must be highly lipid-soluble. According to Fick’s Law of Diffusion, the rate of movement across a biological membrane is directly proportional to the lipid-water partition coefficient [1]. Therefore, lipid solubility is the primary determinant of how effectively a drug can cross the skin into the systemic circulation. 2. Analysis of Incorrect Options: * Molecular Weight (A): While smaller molecules cross more easily, lipid solubility is the more critical prerequisite. Even small molecules cannot cross if they are highly hydrophilic. * Site of Application (B): Skin thickness varies (e.g., thin on the scrotum/post-auricular area, thick on palms/soles), which affects the rate of absorption, but it is not the fundamental property of the drug governing the process. * Nature of the Base (D): The vehicle (ointment vs. cream) can enhance absorption by hydrating the stratum corneum or increasing drug contact time, but it remains secondary to the drug’s intrinsic lipid solubility. Clinical Pearls for NEET-PG: * Hydration: Absorption is significantly increased if the skin is well-hydrated (e.g., using occlusive dressings). * Organophosphates: These are highly lipid-soluble, explaining why systemic toxicity occurs rapidly after accidental skin contact. * Pro-drug approach: Highly polar drugs are often converted into lipid-soluble esters to improve topical penetration.

Q: The action of intravenous thiopentone is terminated by which mechanism?

Redistribution. ### Explanation **Correct Option: C. Redistribution** Thiopentone is a highly lipid-soluble ultra-short-acting barbiturate [1]. When administered intravenously, it rapidly crosses the blood-brain barrier and reaches peak concentrations in the brain (a highly perfused organ) within seconds, leading to immediate induction of anesthesia [5]. However, its action is terminated not by metabolism, but by **redistribution** [1], [3]. As the plasma concentration falls, the drug diffuses out of the brain and moves into less perfused but larger volume tissues, such as skeletal muscles and eventually adipose tissue [1]. This shift lowers the concentration in the brain below the threshold for anesthesia, causing the patient to wake up within 5–10 minutes [2]. **Why other options are incorrect:** * **A. Rapid renal excretion:** Thiopentone is highly lipophilic and undergoes extensive tubular reabsorption; therefore, renal excretion of the unchanged drug is negligible. * **B & D. Oxidation and Conjugation:** While thiopentone is eventually metabolized in the liver (primarily via oxidation), the rate of metabolism is slow (~10–15% per hour) [3]. Metabolism is responsible for the ultimate elimination of the drug from the body, but it is too slow to account for the rapid recovery from a single induction dose [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Context-Sensitive Half-time:** Thiopentone has a long elimination half-life. If given as a repeated infusion, the "storage" sites (fat) become saturated, and recovery then depends on metabolism rather than redistribution, leading to prolonged recovery times [3], [4]. * **Hanging-over effect:** Due to its slow metabolism and gradual release from fat stores, patients often experience post-operative drowsiness [2]. * **Contraindication:** It is strictly contraindicated in **Acute Intermittent Porphyria** as it induces ALA synthase.

Q: A dose-response curve of diazepam was produced alone and in the presence of flumazenil. Which of the following is true regarding the effect of flumazenil on the graph?

Decrease in potency and no effect on efficacy. ### Explanation **Concept: Competitive Antagonism** The interaction between **Diazepam** (a benzodiazepine agonist) and **Flumazenil** (a benzodiazepine antagonist) is the classic example of **competitive (reversible) antagonism**. 1. **Why Option A is Correct:** In competitive antagonism, both the agonist and the antagonist compete for the same binding site on the receptor (GABA-A receptor). * **Potency:** Because the antagonist occupies some receptors, a higher concentration of the agonist (Diazepam) is required to achieve the same effect. This shifts the Dose-Response Curve (DRC) to the **right**, indicating a **decrease in potency** (increase in $EC_{50}$). * **Efficacy:** Since the binding is reversible, the inhibitory effect of Flumazenil can be completely overcome by increasing the dose of Diazepam. Therefore, the maximal response ($E_{max}$) remains unchanged, meaning there is **no effect on efficacy**. 2. **Why Other Options are Incorrect:** * **Option B:** This describes **Non-competitive antagonism**. Non-competitive antagonists bind to allosteric sites or bind irreversibly, reducing the total number of available receptors and thus lowering the maximal response (efficacy). * **Option C:** This would imply no interaction at all. * **Option D:** This is characteristic of a **Non-competitive antagonist** where the $E_{max}$ is reduced but the $EC_{50}$ might remain unchanged. ### NEET-PG High-Yield Pearls * **Flumazenil** is the specific antidote for Benzodiazepine overdose but is **not** effective for Barbiturate or Alcohol toxicity. * **Competitive Antagonist:** Parallel shift of DRC to the right; $V_{max}$ (Efficacy) unchanged; $K_m$ (Potency) decreased. * **Non-competitive Antagonist:** Downward shift of DRC; $V_{max}$ (Efficacy) decreased; $K_m$ (Potency) usually unchanged. * **Inverse Agonist at BZD receptor:** Beta-carbolines (produce anxiety/seizures).

Q: Which one of the following drugs does not have an active metabolite?

Lisinopril. **Explanation The correct answer is **Lisinopril**. **1. Why Lisinopril is correct:** Most ACE inhibitors are **prodrugs** (e.g., Enalapril, Ramipril) that require hepatic conversion into their active "-at" forms (Enalaprilat, Ramiprilat) [2]. However, **Lisinopril** and **Captopril** are the two notable exceptions; they are already in their active form when administered and do not undergo metabolism to form active metabolites [1]. Lisinopril is excreted unchanged by the kidneys. **2. Analysis of Incorrect Options:** * **Diazepam:** This benzodiazepine has a very long half-life because it is metabolized into several active metabolites, including **Nordiazepam** (desmethyldiazepam) and **Oxazepam**. * **Propranolol:** This non-selective beta-blocker undergoes significant first-pass metabolism to form **4-hydroxypropranolol**, which possesses beta-blocking activity. * **Allopurinol:** Used in gout, Allopurinol is rapidly metabolized by xanthine oxidase to its active metabolite, **Alloxanthine (Oxypurinol)**. Alloxanthine has a much longer half-life and is responsible for the sustained inhibition of uric acid synthesis. **3. NEET-PG High-Yield Pearls:** * **ACE Inhibitor Mnemonic:** All ACE inhibitors are prodrugs except **C**aptopril and **L**isinopril (Remember: "**C**heck **L**iver" – these two don't need the liver for activation). * **Active Metabolites to Remember:** * Morphine $\rightarrow$ Morphine-6-glucuronide (more potent) * Spironolactone $\rightarrow$ Canrenone * Amitriptyline $\rightarrow$ Nortriptyline * Codeine $\rightarrow$ Morphine * Lisinopril is preferred in patients with liver disease because it does not require hepatic activation [1].

Question 1

Acetylsalicylic acid and phenobarbitone are better absorbed from the stomach because they are:

Accepted Answer

Weak acids that remain non-ionic in gastric pH

Answer

Weak acids that remain ionic in gastric pH

Answer

Strong acids that are fully ionized in gastric pH

Answer

Weak bases that are ionized at gastric pH

Question 2

Which of the following is an example of a Phase I xenobiotic reaction?

Accepted Answer

Hydroxylation

Answer

Acetylation

Answer

Methylation

Answer

Glucuronidation

Question 3

Which drug follows first-order kinetics for elimination?

Accepted Answer

All of the above

Answer

Opioids

Answer

Verapamil

Answer

Lignocaine

Question 4

Steady-state plasma concentration obtained after a dosage regimen depends on which of the following?

Accepted Answer

Dosing rate

Answer

Duration of action of the drug

Answer

Half-life of a drug

Answer

Dosage interval

Question 5

What is the most important factor governing the absorption of a drug from intact skin?

Accepted Answer

Lipid solubility of the drug

Answer

Molecular weight of the drug

Answer

Site of application

Answer

Nature of the base used in the formulation

Question 6

Which of the following drugs undergoes most of its metabolism presystemically?

Accepted Answer

Propranolol

Answer

Salbutamol

Answer

Verapamil

Answer

Paracetamol

Question 7

The action of intravenous thiopentone is terminated by which mechanism?

Accepted Answer

Redistribution

Answer

Rapid renal excretion

Answer

Oxidation

Answer

Conjugation

Question 8

Which of the following is calculated as the ratio of the area under the curve (AUC) obtained by oral administration versus the AUC for intravenous administration of the same drug?

Accepted Answer

Bioavailability

Answer

Absorption

Answer

Clearance

Answer

Elimination rate constant

Question 9

A dose-response curve of diazepam was produced alone and in the presence of flumazenil. Which of the following is true regarding the effect of flumazenil on the graph?

Accepted Answer

Decrease in potency and no effect on efficacy

Answer

Decrease in potency and decrease in efficacy

Answer

No effect on potency and no effect on efficacy

Answer

No effect on potency and decrease in efficacy

Question 10

Which one of the following drugs does not have an active metabolite?

Accepted Answer

Lisinopril

Answer

Diazepam

Answer

Propranolol

Answer

Allopurinol

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?